No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
BBH VanEck Biotech ETF
- 159.616
- +0.976+0.62%
Trading May 2 10:49 ET
159.616High158.650Low
159.616High158.650Low2.03KVolume160.240Open158.640Pre Close322.72KTurnover0.08%Turnover Ratio--P/E (Static)2.60MShares171.04552wk High--P/B415.00MFloat Cap141.88452wk Low0.71Dividend TTM2.60MShs Float219.780Historical High0.45%Div YieldTTM0.61%Amplitude33.940Historical Low159.133Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Industry Comparison: Evaluating Regeneron Pharmaceuticals Against Competitors In Biotechnology Industry
In the ever-evolving and intensely competitive business landscape, conducting a thorough company analysis is of utmost importance for investors and industry followers. In this article, we will carry o
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years
Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years by 15.96% on an annualized basis producing an average annual return of 23.84%. Currently, Regeneron Pharmaceu
C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Dow Jones index gaining over 50 points on Thursday.Shares of C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) rose sharply during Thursday's session after the company repo
Express News | Moderna Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results
IQVIA Holdings Inc (IQV) First Quarter 2024 Earnings: Surpasses Revenue Estimates
Form 144 | Vertex Pharmaceuticals(VRTX.US) Director Proposes to Sell 188.18K in Common Stocks
SEC FILLINGS DISCLOSED/ May 2, $Vertex Pharmaceuticals(VRTX.US)$ Director Bhatia Sangeeta N. intends to sell 467 shares of its common stock on May 2, with a total market value of approximately $188.18
Comments
Healthcare and Biotech are Absolutely Ripping!
These are the best performing sectors to start the first day of the new year.
This could be due to the fact that biotech and healthcare were nowhere near the top performers last year.
The defensive aspect of these sectors could be adding to their appeal since SPY is starting off 2024 on a bad foot.
If you like these sectors, then I suggest checking out the well-known large cap companies in these sectors as an investment prospect. Here are just a few...
This could be due to the fact that biotech and healthcare were nowhere near the top performers last year.
The defensive aspect of these sectors could be adding to their appeal since SPY is starting off 2024 on a bad foot.
If you like these sectors, then I suggest checking out the well-known large cap companies in these sectors as an investment prospect. Here are just a few...
10
Read more